Metronidazole

Product NDC
46708-021
11-digit product format
467080021
Labeler code
46708
Product ID
46708-021_1e73c48c-80c3-4565-b11e-65e992c3c03a
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Metronidazole
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Labeler
Alembic Pharmaceuticals Limited
Application
ANDA090222
Marketing category
ANDA
Marketing start
2010-05-07
Substance
METRONIDAZOLE
Active strength
750 mg/1
Pharmacologic classes
Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Metronidazole
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
METRONIDAZOLE750 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii140QMO216E
Rxcui636559

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
8ffb9b1d-3ed7-ba2e-677e-47d4d134fd55Product name520251024
7f6d14e0-4366-41bc-a4a9-b74c79a20e17Product name120250623
e6d321b0-0e5e-7da6-f043-92b6a91f00a1Product name520250515
e1aac33b-94ae-4ee9-905b-299f7263853bProduct name320250124
16642716-d28a-4f90-8dcb-3921cd8c8109Product name420240516
0be8e4ae-4d57-49f3-b3a9-e4728b4e8d15Product name120240313
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408
a5070875-62bb-61e1-fd46-8f7054197a40Product name820180215
0add4de9-d152-3375-3390-1123dddc5e3dProduct name120140508
33ca0fcc-1011-92dc-50a9-a383683eed1eProduct name120140508
53f39d9f-cd3f-04e1-c668-d4580719d57dProduct name120140508
a804000f-b74f-0b5d-d17b-aa767c286ddbProduct name120140508
a91ea265-6e02-c08f-93c8-686d54180529Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
46708-021-302023-02-01C16284748780-1f386c64a-1261-0266-e053-dadaa90a7c1aMetronidazole Extended-Release Tablets To reduce the development of drug-resistant bacteria and maintain the effectiveness of metronidazole extended-release tablets, and other antibacterial drugs, metronidazole extended-release tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
46708-021-312023-02-01C16284748780-1f386c64a-1261-0266-e053-dadaa90a7c1aMetronidazole Extended-Release Tablets To reduce the development of drug-resistant bacteria and maintain the effectiveness of metronidazole extended-release tablets, and other antibacterial drugs, metronidazole extended-release tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
46708-021-502023-02-01C16284748780-1f386c64a-1261-0266-e053-dadaa90a7c1aMetronidazole Extended-Release Tablets To reduce the development of drug-resistant bacteria and maintain the effectiveness of metronidazole extended-release tablets, and other antibacterial drugs, metronidazole extended-release tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
46708-021-712023-02-01C16284748780-1f386c64a-1261-0266-e053-dadaa90a7c1aMetronidazole Extended-Release Tablets To reduce the development of drug-resistant bacteria and maintain the effectiveness of metronidazole extended-release tablets, and other antibacterial drugs, metronidazole extended-release tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
46708-021-302023-01-30C16284748780-1f386c64a-1261-0266-e053-dadaa90a7c1aMetronidazole Extended-Release Tablets To reduce the development of drug-resistant bacteria and maintain the effectiveness of metronidazole extended-release tablets, and other antibacterial drugs, metronidazole extended-release tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
46708-021-312023-01-30C16284748780-1f386c64a-1261-0266-e053-dadaa90a7c1aMetronidazole Extended-Release Tablets To reduce the development of drug-resistant bacteria and maintain the effectiveness of metronidazole extended-release tablets, and other antibacterial drugs, metronidazole extended-release tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
46708-021-502023-01-30C16284748780-1f386c64a-1261-0266-e053-dadaa90a7c1aMetronidazole Extended-Release Tablets To reduce the development of drug-resistant bacteria and maintain the effectiveness of metronidazole extended-release tablets, and other antibacterial drugs, metronidazole extended-release tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
46708-021-712023-01-30C16284748780-1f386c64a-1261-0266-e053-dadaa90a7c1aMetronidazole Extended-Release Tablets To reduce the development of drug-resistant bacteria and maintain the effectiveness of metronidazole extended-release tablets, and other antibacterial drugs, metronidazole extended-release tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
46708-021-30Metronidazole30 in 1 BOTTLETABLET, FILM COATED, EXTENDED RE3013
46708-021-31Metronidazole100 in 1 BOTTLETABLET, FILM COATED, EXTENDED RE10013
46708-021-50Metronidazole50 in 1 BOTTLETABLET, FILM COATED, EXTENDED RE5013
46708-021-71Metronidazole500 in 1 BOTTLETABLET, FILM COATED, EXTENDED RE50013

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
46708-021METRONIDAZOLE TABLET, FILM COATED, EXTENDED RELEASE [ALEMBIC PHARMACEUTICALS LIMITED]13Current NDC, Legacy NDC, 4 package rows20230202_80c79325-1ea4-46f8-b9b8-967b7640c51d.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
636559metroNIDAZOLE 750 MG 24HR Extended Release Oral TabletPSN80c79325-1ea4-46f8-b9b8-967b7640c51d13
63655924 HR metronidazole 750 MG Extended Release Oral TabletSCD80c79325-1ea4-46f8-b9b8-967b7640c51d13
636559metronidazole 750 MG 24 HR Extended Release Oral TabletSY80c79325-1ea4-46f8-b9b8-967b7640c51d13

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
46708-021-304670800213030 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (46708-021-30) 2010-05-070000-00-00NoNoCurrent
46708-021-3146708002131100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (46708-021-31) 2010-05-070000-00-00NoNoCurrent
46708-021-504670800215050 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (46708-021-50) 2010-05-070000-00-00NoNoCurrent
46708-021-7146708002171500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (46708-021-71) 2010-05-070000-00-00NoNoCurrent